News and Comments

Biotech Firms with Guaranteed Growth Potential

  Thursday, July 07, 2016

Good news is not always great news that makes a difference. In the drug industry, clinical trial results that demonstrate a drug has fulfilled the requirements of the trials, including the primary and secondary endpoints does not always guarantee that the drug will be successful if and when it hits the market. Experience and follow up on certain firms enables us to see the real light at the end of the tunnel, not just celebrate reaching the end of it without knowing what to expect outside. This makes a big difference.  More...

THERAVANCE: BECAME TEMPTING TO INVESTORS ANR TO ITS PARTNER

  Monday, January 07, 2013

Using scientific skills towards building pipelines of promising products does not guarantee a happy ending for a small biotech firm. Pipelines’ breakthroughs need managements’ capabilities and swiftness of actions, which would walk them through the safest and fastest road towards approvals.  We believe Theravance (THRX) has benefited from both its scientists and management. The firm has come nearer than ever to reaching a happy beginning of substantial growth, or perhaps, a happy ending through acquisition, probably, by its partner GlaxoSmithKline (GSK).  More...


Recent Postings


Archive


Tags

Xoma (XOMA) Ocular Therapeutix (OCUL) Amgen (AMGN) Pluristem (PSTI) PTC Therapeutics (PTCT) Theravance (THRX) Adaptimmune (ADAP) Spike Therapeutics (ONCE) CompuGen (CGEN) Rapamune ADVENTRIX (ANX) IDERA (IDRA) Sanofi-Aventis (SAN) Prosensa (RNA) Seattle Genetics (SGEN) ISIS (ISIS) Sangamo (SGMO) Alder Biopharmaceuticals (ALDR) NEKTAR (NKTR)) Trastuzumab-DM1 Theravance Bio Pharma (TBPH) RenenxBio (RGNX) Regeneron (REGN) Exelixis (EXEL) Merck (MRK) OSI (OSIP) Anadys (ANDS) Mirati Therapeutics (MRTX) JOUNCE THERAPEUTICS (JNCE) Micromet (MITI) Elan (ELN) Vertex (VRTX) VANDA (VNDA) GlaxoSmithKline (GSK) Roche (ROCHE) Incyte (INCY) Benlysta (belimumab) Gilead (GILD) NANTKWEST (NK) Human Genome Sciences (HGSI) Biogen Idec (BIIB) ImmunoGen (IMGN) BIOMARIN (BMRN) INNOVIVA (INVA) Global Cell Therapeutics (GBT) Ziofpharm (ZIOP) Zerenex Endometrial Cancer galapagos (GLPG) PORTOLA (PTLA) Auspex (ASPX) Tysabri Aimmune Therapeutics (AIMT) JUNO (JUNO) Biocryst (BCRX) SERES THERAPEUTICS (MCRB) HALOZYME (HALO) Agenus (AGEN Abbott Laboratories (ABT) Genentech Velcade (bortezomib) Editas (EDIT) Idenix (IDIX) Intrexon (XON) GUARDIAN HEALTH Telaprevir C4 Therapeutics SYNTA (SNTA) Vitae Pharmaceuticals (VTAE) Illumina (ILMN) Valeant Pharmaceuticals International (VRX) CEMPRA (CEMP) Bellicum (BLCM) Cytokinetics (CYTK) Ridaforolimus CRISPR Therapeutics (CRSP) ZALTRAP™ KITE (KITE) Multiple Myeloma Ionis (IONS) Onyx (ONXX) KERYX (KERX) Array Pharmaceuticals (ARRY) ARCA (ABIO) Bristol-Myers Squibb (BMY) TOKAI (TKAOI) Sanofi (SNY) ABBVIE (ABBV) Jazz Pharmaceuticals (JAZZ) AGOS (ARGS) Alnylam (ALNY) Intermune (ITMN) Intercept (ICPT) Ariad (ARIA) NOVOCURE (NVCR) Sarepta (SRPT) AERIE PHARMACEUTICALS Sequenom (SQNM) Herceptin Agenus (AGEN) Anacor (ANAC) AstraZeneca (AZN) Sanofi (SNA) SUNESIS PHARMACEUTICALS (SNSS) Human Longevity (HLI) REGULUS (RGLS) MODERNA Revlimid (lenolidamide) Dendreon (DNDN) Roche (RHHBY) ARGOS (ARGS) Prolor Biotech (PBTH) ACADIA (ACAD) Galena (GALE) Dynavax (DVAX) Advaxis (ADXS) Inovio (INO)